SNORD67 and neoplasm: Although the EO771.LMB Snord67 knockout clone and one 4T1 Snord67 knockout clone demonstrated significantly decreased MFP tumor growth after mammary fat pad injection, MFP tumor growth was unaffected in the second 4T1 Snord67 knockout clone (Fig. 5D, E).